Your browser doesn't support javascript.
loading
A protein quality control pathway regulated by linear ubiquitination.
van Well, Eva M; Bader, Verian; Patra, Maria; Sánchez-Vicente, Ana; Meschede, Jens; Furthmann, Nikolas; Schnack, Cathrin; Blusch, Alina; Longworth, Joseph; Petrasch-Parwez, Elisabeth; Mori, Kohji; Arzberger, Thomas; Trümbach, Dietrich; Angersbach, Lena; Showkat, Cathrin; Sehr, Dominik A; Berlemann, Lena A; Goldmann, Petra; Clement, Albrecht M; Behl, Christian; Woerner, Andreas C; Saft, Carsten; Wurst, Wolfgang; Haass, Christian; Ellrichmann, Gisa; Gold, Ralf; Dittmar, Gunnar; Hipp, Mark S; Hartl, F Ulrich; Tatzelt, Jörg; Winklhofer, Konstanze F.
Afiliação
  • van Well EM; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Bader V; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Patra M; Neurobiochemistry, Adolf Butenandt Institute, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Sánchez-Vicente A; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Meschede J; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Furthmann N; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Schnack C; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Blusch A; Department of Neurology, St Josef Hospital, Ruhr University Bochum, Bochum, Germany.
  • Longworth J; Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Petrasch-Parwez E; Department of Neuroanatomy and Molecular Brain Research, Ruhr University Bochum, Bochum, Germany.
  • Mori K; Biomedical Center (BMC), Ludwig-Maximilians-University Munich, Munich, Germany.
  • Arzberger T; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Trümbach D; Centre for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Angersbach L; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
  • Showkat C; Institute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Sehr DA; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Berlemann LA; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Goldmann P; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Clement AM; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Behl C; Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, Bochum, Germany.
  • Woerner AC; Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • Saft C; Institute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
  • Wurst W; Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Haass C; Department of Neurology, St Josef Hospital, Ruhr University Bochum, Bochum, Germany.
  • Ellrichmann G; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
  • Gold R; Institute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Dittmar G; Developmental Genetics, Technical University Munich, Neuherberg, Germany.
  • Hipp MS; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Hartl FU; Biomedical Center (BMC), Ludwig-Maximilians-University Munich, Munich, Germany.
  • Tatzelt J; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
  • Winklhofer KF; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
EMBO J ; 38(9)2019 05 02.
Article em En | MEDLINE | ID: mdl-30886048
ABSTRACT
Neurodegenerative diseases are characterized by the accumulation of misfolded proteins in the brain. Insights into protein quality control mechanisms to prevent neuronal dysfunction and cell death are crucial in developing causal therapies. Here, we report that various disease-associated protein aggregates are modified by the linear ubiquitin chain assembly complex (LUBAC). HOIP, the catalytic component of LUBAC, is recruited to misfolded Huntingtin in a p97/VCP-dependent manner, resulting in the assembly of linear polyubiquitin. As a consequence, the interactive surface of misfolded Huntingtin species is shielded from unwanted interactions, for example with the low complexity sequence domain-containing transcription factor Sp1, and proteasomal degradation of misfolded Huntingtin is facilitated. Notably, all three core LUBAC components are transcriptionally regulated by Sp1, linking defective LUBAC expression to Huntington's disease. In support of a protective activity of linear ubiquitination, silencing of OTULIN, a deubiquitinase with unique specificity for linear polyubiquitin, decreases proteotoxicity, whereas silencing of HOIP has the opposite effect. These findings identify linear ubiquitination as a protein quality control mechanism and hence a novel target for disease-modifying strategies in proteinopathies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Processamento de Proteína Pós-Traducional / Fator de Transcrição Sp1 / Doença de Huntington / Poliubiquitina / Proteína Huntingtina / Proteína com Valosina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Processamento de Proteína Pós-Traducional / Fator de Transcrição Sp1 / Doença de Huntington / Poliubiquitina / Proteína Huntingtina / Proteína com Valosina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article